Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.50711214 |
2 | regulation of vitamin metabolic process (GO:0030656) | 5.25302079 |
3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.20827455 |
4 | modulation by symbiont of host defense response (GO:0052031) | 5.20827455 |
5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.20827455 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.20827455 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.20827455 |
8 | modulation by symbiont of host immune response (GO:0052553) | 5.20827455 |
9 | response to peptidoglycan (GO:0032494) | 4.45157255 |
10 | response to muramyl dipeptide (GO:0032495) | 4.30964341 |
11 | regulation of chronic inflammatory response (GO:0002676) | 4.24583351 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18663092 |
13 | regulation of podosome assembly (GO:0071801) | 4.13827515 |
14 | positive regulation of interferon-alpha production (GO:0032727) | 4.06826246 |
15 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.06327949 |
16 | macrophage activation involved in immune response (GO:0002281) | 4.04984753 |
17 | neutrophil activation involved in immune response (GO:0002283) | 4.04096578 |
18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93728470 |
19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.93044958 |
20 | positive regulation of heat generation (GO:0031652) | 3.91447223 |
21 | regulation of interferon-alpha production (GO:0032647) | 3.89569527 |
22 | regulation of mononuclear cell migration (GO:0071675) | 3.86624479 |
23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.84000746 |
24 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.80176500 |
25 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.75006915 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 3.60288427 |
27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42514203 |
28 | response to host immune response (GO:0052572) | 3.42514203 |
29 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38681411 |
30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36659791 |
31 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35755359 |
32 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.34927807 |
33 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.31619357 |
34 | monocyte chemotaxis (GO:0002548) | 3.31090913 |
35 | microglial cell activation (GO:0001774) | 3.30922362 |
36 | immunoglobulin mediated immune response (GO:0016064) | 3.28299312 |
37 | granulocyte activation (GO:0036230) | 3.28254909 |
38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.28149888 |
39 | regulation of fever generation (GO:0031620) | 3.27774874 |
40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.27508692 |
41 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27508692 |
42 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23699507 |
43 | negative regulation of interleukin-12 production (GO:0032695) | 3.22732260 |
44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.22719706 |
45 | positive regulation of acute inflammatory response (GO:0002675) | 3.20890715 |
46 | positive regulation of type 2 immune response (GO:0002830) | 3.20812214 |
47 | neutrophil activation (GO:0042119) | 3.19077700 |
48 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.17633238 |
49 | response to protozoan (GO:0001562) | 3.17407525 |
50 | low-density lipoprotein particle clearance (GO:0034383) | 3.16647139 |
51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15204777 |
52 | response to host (GO:0075136) | 3.14239156 |
53 | response to host defenses (GO:0052200) | 3.14239156 |
54 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14239156 |
55 | positive regulation of interferon-beta production (GO:0032728) | 3.11498963 |
56 | * cellular response to lipopolysaccharide (GO:0071222) | 3.11469845 |
57 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09105824 |
58 | respiratory burst (GO:0045730) | 3.08503029 |
59 | positive regulation of interleukin-6 production (GO:0032755) | 3.07946768 |
60 | positive regulation of interleukin-12 production (GO:0032735) | 3.07633448 |
61 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.07229742 |
62 | regulation of immunoglobulin secretion (GO:0051023) | 3.04436254 |
63 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.03312848 |
64 | detection of molecule of bacterial origin (GO:0032490) | 3.03193569 |
65 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.03107853 |
66 | negative regulation of lipid storage (GO:0010888) | 3.02782779 |
67 | macrophage activation (GO:0042116) | 3.02072052 |
68 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99164769 |
69 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.98738984 |
70 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.98630636 |
71 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.96904416 |
72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.96361659 |
73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94591251 |
74 | regulation of gamma-delta T cell activation (GO:0046643) | 2.94038125 |
75 | regulation of heat generation (GO:0031650) | 2.93163695 |
76 | cellular response to nicotine (GO:0071316) | 2.92788331 |
77 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.90973392 |
78 | response to type I interferon (GO:0034340) | 2.90220033 |
79 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.89453714 |
80 | cellular response to type I interferon (GO:0071357) | 2.89330946 |
81 | type I interferon signaling pathway (GO:0060337) | 2.89330946 |
82 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.87213479 |
83 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.86946039 |
84 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.86850235 |
85 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84043697 |
86 | regulation of cholesterol storage (GO:0010885) | 2.83355682 |
87 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.83171403 |
88 | germinal center formation (GO:0002467) | 2.83016296 |
89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82134071 |
90 | cytokine secretion (GO:0050663) | 2.81816324 |
91 | regulation of antigen processing and presentation (GO:0002577) | 2.81753452 |
92 | cellular response to ethanol (GO:0071361) | 2.80869220 |
93 | superoxide anion generation (GO:0042554) | 2.80695456 |
94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.80389993 |
95 | regulation of interleukin-12 production (GO:0032655) | 2.80086563 |
96 | myeloid cell activation involved in immune response (GO:0002275) | 2.79610058 |
97 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.79380350 |
98 | regulation of growth of symbiont in host (GO:0044126) | 2.79380350 |
99 | negative regulation of growth of symbiont in host (GO:0044130) | 2.79380350 |
100 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.79380350 |
101 | oligosaccharide catabolic process (GO:0009313) | 2.77956732 |
102 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77681931 |
103 | positive regulation of chemokine production (GO:0032722) | 2.76821230 |
104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76346557 |
105 | leukocyte aggregation (GO:0070486) | 2.75839863 |
106 | regulation of prostaglandin secretion (GO:0032306) | 2.74703821 |
107 | I-kappaB phosphorylation (GO:0007252) | 2.74318724 |
108 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.73798753 |
109 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.72603604 |
110 | positive regulation of interleukin-17 production (GO:0032740) | 2.72364468 |
111 | T-helper 1 type immune response (GO:0042088) | 2.72286146 |
112 | tolerance induction (GO:0002507) | 2.70344842 |
113 | regulation of T-helper cell differentiation (GO:0045622) | 2.69548221 |
114 | regulation of interleukin-6 production (GO:0032675) | 2.69278033 |
115 | regulation of chemokine biosynthetic process (GO:0045073) | 2.66696665 |
116 | myeloid dendritic cell differentiation (GO:0043011) | 2.66659183 |
117 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.66243739 |
118 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.64432634 |
119 | cellular response to arsenic-containing substance (GO:0071243) | 2.64389250 |
120 | * cellular response to biotic stimulus (GO:0071216) | 2.63595956 |
121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.62024147 |
122 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.61026662 |
123 | positive regulation of B cell differentiation (GO:0045579) | 2.60396285 |
124 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.60335465 |
125 | cellular extravasation (GO:0045123) | 2.60130611 |
126 | detection of other organism (GO:0098543) | 2.59381108 |
127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.59295794 |
128 | positive regulation of humoral immune response (GO:0002922) | 2.58903865 |
129 | eosinophil chemotaxis (GO:0048245) | 2.58801074 |
130 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.58600531 |
131 | glycosphingolipid catabolic process (GO:0046479) | 2.57531401 |
132 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.57226488 |
133 | mature B cell differentiation (GO:0002335) | 2.57067823 |
134 | natural killer cell mediated immunity (GO:0002228) | 2.56953468 |
135 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.56953468 |
136 | T cell migration (GO:0072678) | 2.56800613 |
137 | positive regulation of lipid storage (GO:0010884) | 2.56730969 |
138 | regulation of mast cell degranulation (GO:0043304) | 2.53807590 |
139 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.52870467 |
140 | defense response to protozoan (GO:0042832) | 2.52061245 |
141 | myeloid dendritic cell activation (GO:0001773) | 2.50252768 |
142 | reactive oxygen species biosynthetic process (GO:1903409) | 2.49610131 |
143 | detection of external biotic stimulus (GO:0098581) | 2.49300075 |
144 | regulation of interleukin-17 production (GO:0032660) | 2.48532277 |
145 | cellular response to virus (GO:0098586) | 2.45415602 |
146 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.45216244 |
147 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.43207090 |
148 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.43075724 |
149 | leukocyte cell-cell adhesion (GO:0007159) | 2.42808821 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.69684428 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.12407258 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.27867564 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.77327791 |
5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.66506690 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.50165947 |
7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.49087843 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.41479539 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37471856 |
10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.26559156 |
11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16962719 |
12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.16014463 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76793909 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.68128911 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.61099788 |
16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58442462 |
17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.52091654 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.49256529 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31656235 |
20 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26480715 |
21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22235291 |
22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20601744 |
23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13509235 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11751669 |
25 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11040400 |
26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.10538976 |
27 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00011993 |
28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99749465 |
29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98292158 |
30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.97917138 |
31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95777653 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91478709 |
33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.84839894 |
34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75987904 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.74186985 |
36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71189843 |
37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.66154281 |
38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65498885 |
39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63220860 |
40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62931781 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.60703996 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59136414 |
43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58938018 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57908162 |
45 | MAF_26560356_Chip-Seq_TH1_Human | 1.57776818 |
46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55544789 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54625913 |
48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50217161 |
49 | MYB_26560356_Chip-Seq_TH1_Human | 1.50037204 |
50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48927435 |
51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48590574 |
52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45210019 |
53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35555623 |
54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34971173 |
55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.29273484 |
56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26963449 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26282850 |
58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26222383 |
59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.25195075 |
60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21545922 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19616340 |
62 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16987108 |
63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14206826 |
64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11858966 |
65 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09893517 |
66 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08207852 |
67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08107750 |
68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08068149 |
69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07790641 |
70 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07684397 |
71 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06862076 |
72 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06580677 |
73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05407576 |
74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04820462 |
75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04710046 |
76 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.03779870 |
77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03450959 |
78 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02235123 |
79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02153038 |
80 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02090017 |
81 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01540360 |
82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01200897 |
83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99870289 |
84 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99792617 |
85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.98610430 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98419676 |
87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.97238495 |
88 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.97228476 |
89 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.97103079 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96847721 |
91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95411555 |
92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95411555 |
93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.94288801 |
94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92099921 |
95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91884034 |
96 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91410793 |
97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89885316 |
98 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.88157904 |
99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87555265 |
100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86536495 |
101 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.85684134 |
102 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85289143 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84745777 |
104 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.84624029 |
105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84221205 |
106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82335648 |
107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82084427 |
108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81784103 |
109 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.81686015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.65758512 |
2 | MP0003436_decreased_susceptibility_to | 3.23513455 |
3 | MP0009785_altered_susceptibility_to | 3.14455398 |
4 | MP0003303_peritoneal_inflammation | 2.89398840 |
5 | MP0005387_immune_system_phenotype | 2.83299771 |
6 | MP0001790_abnormal_immune_system | 2.83299771 |
7 | * MP0002419_abnormal_innate_immunity | 2.73521979 |
8 | MP0005000_abnormal_immune_tolerance | 2.72947215 |
9 | MP0000685_abnormal_immune_system | 2.62770411 |
10 | MP0003724_increased_susceptibility_to | 2.61854882 |
11 | MP0002148_abnormal_hypersensitivity_rea | 2.59061025 |
12 | MP0006082_CNS_inflammation | 2.55694743 |
13 | MP0001800_abnormal_humoral_immune | 2.53959382 |
14 | MP0005025_abnormal_response_to | 2.48846288 |
15 | MP0005671_abnormal_response_to | 2.45478263 |
16 | * MP0002452_abnormal_antigen_presenting | 2.43546719 |
17 | MP0009840_abnormal_foam_cell | 2.34216146 |
18 | * MP0002723_abnormal_immune_serum | 2.30832907 |
19 | MP0004510_myositis | 2.18521693 |
20 | MP0005058_abnormal_lysosome_morphology | 2.17905058 |
21 | MP0004947_skin_inflammation | 2.10409740 |
22 | * MP0001819_abnormal_immune_cell | 2.00700233 |
23 | MP0008004_abnormal_stomach_pH | 1.99929188 |
24 | MP0001853_heart_inflammation | 1.99589891 |
25 | * MP0002420_abnormal_adaptive_immunity | 1.98494101 |
26 | MP0005464_abnormal_platelet_physiology | 1.96950710 |
27 | MP0002254_reproductive_system_inflammat | 1.93214384 |
28 | MP0003195_calcinosis | 1.91502589 |
29 | MP0002405_respiratory_system_inflammati | 1.86436878 |
30 | MP0003191_abnormal_cellular_cholesterol | 1.86182324 |
31 | MP0002332_abnormal_exercise_endurance | 1.84915774 |
32 | MP0010155_abnormal_intestine_physiology | 1.80851955 |
33 | * MP0009764_decreased_sensitivity_to | 1.80150340 |
34 | * MP0001845_abnormal_inflammatory_respons | 1.79220946 |
35 | MP0001533_abnormal_skeleton_physiology | 1.79081311 |
36 | MP0006054_spinal_hemorrhage | 1.69704356 |
37 | MP0003300_gastrointestinal_ulcer | 1.68300705 |
38 | * MP0008469_abnormal_protein_level | 1.67953473 |
39 | MP0005360_urolithiasis | 1.67744476 |
40 | MP0002138_abnormal_hepatobiliary_system | 1.66203565 |
41 | MP0009278_abnormal_bone_marrow | 1.66153988 |
42 | MP0000343_altered_response_to | 1.57143155 |
43 | MP0001873_stomach_inflammation | 1.52956995 |
44 | MP0003448_altered_tumor_morphology | 1.49295529 |
45 | MP0003172_abnormal_lysosome_physiology | 1.48945822 |
46 | MP0000716_abnormal_immune_system | 1.45905525 |
47 | MP0002139_abnormal_hepatobiliary_system | 1.44999064 |
48 | MP0005397_hematopoietic_system_phenotyp | 1.40698390 |
49 | MP0001545_abnormal_hematopoietic_system | 1.40698390 |
50 | MP0002006_tumorigenesis | 1.40631474 |
51 | MP0003075_altered_response_to | 1.38870175 |
52 | MP0002998_abnormal_bone_remodeling | 1.38202941 |
53 | MP0002398_abnormal_bone_marrow | 1.36507600 |
54 | MP0009333_abnormal_splenocyte_physiolog | 1.35996701 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.29775894 |
56 | MP0000689_abnormal_spleen_morphology | 1.27370350 |
57 | MP0003806_abnormal_nucleotide_metabolis | 1.24237725 |
58 | MP0000604_amyloidosis | 1.24145944 |
59 | MP0000858_altered_metastatic_potential | 1.23840426 |
60 | MP0002166_altered_tumor_susceptibility | 1.23035427 |
61 | MP0003950_abnormal_plasma_membrane | 1.21913616 |
62 | MP0003183_abnormal_peptide_metabolism | 1.18748385 |
63 | MP0000609_abnormal_liver_physiology | 1.18017774 |
64 | MP0002429_abnormal_blood_cell | 1.16693246 |
65 | MP0000569_abnormal_digit_pigmentation | 1.16340065 |
66 | MP0004782_abnormal_surfactant_physiolog | 1.13189888 |
67 | MP0002722_abnormal_immune_system | 1.12482454 |
68 | MP0005166_decreased_susceptibility_to | 1.12347254 |
69 | MP0008260_abnormal_autophagy | 1.11628268 |
70 | MP0009763_increased_sensitivity_to | 1.10759639 |
71 | MP0003453_abnormal_keratinocyte_physiol | 1.09823738 |
72 | MP0005310_abnormal_salivary_gland | 1.08975006 |
73 | MP0003566_abnormal_cell_adhesion | 1.08543622 |
74 | MP0005365_abnormal_bile_salt | 1.06249655 |
75 | MP0010329_abnormal_lipoprotein_level | 1.03867466 |
76 | MP0003690_abnormal_glial_cell | 1.02391060 |
77 | MP0003828_pulmonary_edema | 1.00484912 |
78 | MP0003656_abnormal_erythrocyte_physiolo | 1.00378404 |
79 | MP0003763_abnormal_thymus_physiology | 1.00217521 |
80 | MP0002933_joint_inflammation | 0.99953659 |
81 | MP0002877_abnormal_melanocyte_morpholog | 0.99368003 |
82 | MP0003186_abnormal_redox_activity | 0.98251661 |
83 | MP0004019_abnormal_vitamin_homeostasis | 0.98180179 |
84 | MP0002136_abnormal_kidney_physiology | 0.96662773 |
85 | MP0005164_abnormal_response_to | 0.96162541 |
86 | MP0003646_muscle_fatigue | 0.95712698 |
87 | MP0005085_abnormal_gallbladder_physiolo | 0.95532729 |
88 | MP0003252_abnormal_bile_duct | 0.95349008 |
89 | MP0002277_abnormal_respiratory_mucosa | 0.94872963 |
90 | MP0000249_abnormal_blood_vessel | 0.94223400 |
91 | MP0005165_increased_susceptibility_to | 0.90682364 |
92 | MP0000465_gastrointestinal_hemorrhage | 0.86272390 |
93 | MP0005076_abnormal_cell_differentiation | 0.86147771 |
94 | MP0005670_abnormal_white_adipose | 0.85084360 |
95 | MP0001851_eye_inflammation | 0.83907055 |
96 | MP0003091_abnormal_cell_migration | 0.82954904 |
97 | MP0005319_abnormal_enzyme/_coenzyme | 0.82582539 |
98 | MP0005390_skeleton_phenotype | 0.82054155 |
99 | MP0003045_fibrosis | 0.81807180 |
100 | MP0001881_abnormal_mammary_gland | 0.79806254 |
101 | MP0005451_abnormal_body_composition | 0.79234419 |
102 | MP0000920_abnormal_myelination | 0.78771468 |
103 | MP0010352_gastrointestinal_tract_polyps | 0.77676594 |
104 | MP0003866_abnormal_defecation | 0.76428954 |
105 | MP0005083_abnormal_biliary_tract | 0.75746961 |
106 | MP0005023_abnormal_wound_healing | 0.74893830 |
107 | MP0008874_decreased_physiological_sensi | 0.73463236 |
108 | MP0001501_abnormal_sleep_pattern | 0.72940943 |
109 | MP0005535_abnormal_body_temperature | 0.71638507 |
110 | MP0009643_abnormal_urine_homeostasis | 0.71364350 |
111 | MP0001663_abnormal_digestive_system | 0.69521959 |
112 | MP0002118_abnormal_lipid_homeostasis | 0.68951937 |
113 | MP0009765_abnormal_xenobiotic_induced | 0.68145810 |
114 | MP0000371_diluted_coat_color | 0.67961303 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.67559948 |
116 | MP0005647_abnormal_sex_gland | 0.61680345 |
117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.61419104 |
118 | MP0003795_abnormal_bone_structure | 0.60982647 |
119 | MP0004883_abnormal_blood_vessel | 0.57707082 |
120 | MP0005266_abnormal_metabolism | 0.53881942 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.70832558 |
2 | Eczematoid dermatitis (HP:0000976) | 5.53167465 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.50990095 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.79569489 |
5 | Orchitis (HP:0100796) | 4.75380739 |
6 | Retrobulbar optic neuritis (HP:0100654) | 4.70037977 |
7 | Optic neuritis (HP:0100653) | 4.70037977 |
8 | Myositis (HP:0100614) | 4.52245766 |
9 | Abnormality of macrophages (HP:0004311) | 4.35498930 |
10 | Stomatitis (HP:0010280) | 4.25431279 |
11 | Mediastinal lymphadenopathy (HP:0100721) | 4.09141166 |
12 | Autoimmune thrombocytopenia (HP:0001973) | 4.06817236 |
13 | Loss of speech (HP:0002371) | 3.90974625 |
14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86846331 |
15 | Systemic lupus erythematosus (HP:0002725) | 3.84232082 |
16 | Recurrent skin infections (HP:0001581) | 3.76342326 |
17 | Recurrent fungal infections (HP:0002841) | 3.69919663 |
18 | Myocardial infarction (HP:0001658) | 3.64895504 |
19 | Vasculitis (HP:0002633) | 3.46488897 |
20 | Vacuolated lymphocytes (HP:0001922) | 3.43497642 |
21 | Gingivitis (HP:0000230) | 3.28270254 |
22 | Pustule (HP:0200039) | 3.20440453 |
23 | Disinhibition (HP:0000734) | 3.18514755 |
24 | Gangrene (HP:0100758) | 3.16773314 |
25 | Recurrent viral infections (HP:0004429) | 3.15131147 |
26 | Pulmonary infiltrates (HP:0002113) | 3.12044933 |
27 | Keratoconjunctivitis sicca (HP:0001097) | 3.05706126 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98561480 |
29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98561480 |
30 | Arterial thrombosis (HP:0004420) | 2.97510544 |
31 | Neurofibrillary tangles (HP:0002185) | 2.96968168 |
32 | Colitis (HP:0002583) | 2.88893877 |
33 | Keratoconjunctivitis (HP:0001096) | 2.88194516 |
34 | Interstitial pulmonary disease (HP:0006530) | 2.85709503 |
35 | Increased cerebral lipofuscin (HP:0011813) | 2.82224436 |
36 | Mutism (HP:0002300) | 2.78595339 |
37 | Glomerulonephritis (HP:0000099) | 2.76841046 |
38 | Obstructive lung disease (HP:0006536) | 2.75047666 |
39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75047666 |
40 | Periodontitis (HP:0000704) | 2.74069521 |
41 | Tetraparesis (HP:0002273) | 2.72425649 |
42 | Urticaria (HP:0001025) | 2.70276980 |
43 | Gingival bleeding (HP:0000225) | 2.67167025 |
44 | Autoimmune hemolytic anemia (HP:0001890) | 2.66481779 |
45 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.61763653 |
46 | Axonal loss (HP:0003447) | 2.61274977 |
47 | Meningitis (HP:0001287) | 2.59920398 |
48 | Prostate neoplasm (HP:0100787) | 2.59831277 |
49 | Joint hemorrhage (HP:0005261) | 2.58979694 |
50 | Premature loss of primary teeth (HP:0006323) | 2.54361044 |
51 | Nuclear cataract (HP:0100018) | 2.52875408 |
52 | Cellulitis (HP:0100658) | 2.49880849 |
53 | Abnormality of iron homeostasis (HP:0011031) | 2.49432692 |
54 | Anorexia (HP:0002039) | 2.48363445 |
55 | Episodic fever (HP:0001954) | 2.48005654 |
56 | Purpura (HP:0000979) | 2.47483748 |
57 | Abnormality of proline metabolism (HP:0010907) | 2.44575800 |
58 | Hydroxyprolinuria (HP:0003080) | 2.44575800 |
59 | Apathy (HP:0000741) | 2.43001844 |
60 | Polyneuropathy (HP:0001271) | 2.42765140 |
61 | Inflammation of the large intestine (HP:0002037) | 2.42306527 |
62 | Parakeratosis (HP:0001036) | 2.40314579 |
63 | Hematochezia (HP:0002573) | 2.39985927 |
64 | Basal ganglia calcification (HP:0002135) | 2.38945346 |
65 | Thick nail (HP:0001805) | 2.38057854 |
66 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37960760 |
67 | Complement deficiency (HP:0004431) | 2.37827243 |
68 | Osteomyelitis (HP:0002754) | 2.36999438 |
69 | Diminished motivation (HP:0000745) | 2.35163878 |
70 | Amyloidosis (HP:0011034) | 2.35103008 |
71 | Leukocytosis (HP:0001974) | 2.31761812 |
72 | Hemoptysis (HP:0002105) | 2.31273331 |
73 | Gastrointestinal stroma tumor (HP:0100723) | 2.30835757 |
74 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.30462228 |
75 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.30462228 |
76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.30462228 |
77 | Increased IgE level (HP:0003212) | 2.29433464 |
78 | Chronic otitis media (HP:0000389) | 2.28046923 |
79 | Dysostosis multiplex (HP:0000943) | 2.27645847 |
80 | Encephalitis (HP:0002383) | 2.26706554 |
81 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.25180050 |
82 | Gastrointestinal inflammation (HP:0004386) | 2.20824251 |
83 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.18322066 |
84 | IgM deficiency (HP:0002850) | 2.17924945 |
85 | Xanthomatosis (HP:0000991) | 2.17908126 |
86 | Progressive neurologic deterioration (HP:0002344) | 2.16161619 |
87 | Hepatosplenomegaly (HP:0001433) | 2.15481216 |
88 | Nephritis (HP:0000123) | 2.15263975 |
89 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14596787 |
90 | Abnormality of complement system (HP:0005339) | 2.14254229 |
91 | Esophageal varix (HP:0002040) | 2.13494428 |
92 | Cerebral inclusion bodies (HP:0100314) | 2.13022802 |
93 | Recurrent pneumonia (HP:0006532) | 2.12460534 |
94 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11924085 |
95 | Joint swelling (HP:0001386) | 2.10754862 |
96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08888480 |
97 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04079402 |
98 | Osteolytic defects of the hand bones (HP:0009699) | 2.04079402 |
99 | Gastrointestinal infarctions (HP:0005244) | 2.04043879 |
100 | Neuronal loss in central nervous system (HP:0002529) | 2.03905748 |
101 | Mucopolysacchariduria (HP:0008155) | 2.03348090 |
102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03348090 |
103 | Metaphyseal irregularity (HP:0003025) | 2.03159894 |
104 | Abnormality of the pleura (HP:0002103) | 2.01991187 |
105 | Nausea (HP:0002018) | 2.01501999 |
106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00484054 |
107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00484054 |
108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00484054 |
109 | Petechiae (HP:0000967) | 2.00261737 |
110 | Emphysema (HP:0002097) | 2.00256582 |
111 | Arthralgia (HP:0002829) | 1.98038610 |
112 | Agammaglobulinemia (HP:0004432) | 1.97449705 |
113 | Vertigo (HP:0002321) | 1.97352435 |
114 | Epistaxis (HP:0000421) | 1.95656082 |
115 | Pulmonary embolism (HP:0002204) | 1.95656020 |
116 | Bone pain (HP:0002653) | 1.95157650 |
117 | Hypergammaglobulinemia (HP:0010702) | 1.94547122 |
118 | Asymmetric septal hypertrophy (HP:0001670) | 1.94335652 |
119 | Abnormality of the pericardium (HP:0001697) | 1.93555582 |
120 | Glomerulopathy (HP:0100820) | 1.93313402 |
121 | T lymphocytopenia (HP:0005403) | 1.93181403 |
122 | Prolonged neonatal jaundice (HP:0006579) | 1.92397376 |
123 | Increased serum ferritin (HP:0003281) | 1.92094773 |
124 | Cheilitis (HP:0100825) | 1.91850126 |
125 | Eosinophilia (HP:0001880) | 1.91647737 |
126 | Abnormality of T cell number (HP:0011839) | 1.91537576 |
127 | Chronic diarrhea (HP:0002028) | 1.90637722 |
128 | Vertebral compression fractures (HP:0002953) | 1.90528923 |
129 | Increased IgM level (HP:0003496) | 1.90132130 |
130 | IgA deficiency (HP:0002720) | 1.90129467 |
131 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89658518 |
132 | Fatigue (HP:0012378) | 1.83779745 |
133 | Acne (HP:0001061) | 1.83290680 |
134 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82472296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.69814137 |
2 | TBK1 | 3.53443655 |
3 | MAP4K1 | 3.39133146 |
4 | TYK2 | 3.29774570 |
5 | TXK | 3.11450839 |
6 | DDR2 | 2.92159736 |
7 | IKBKE | 2.78120099 |
8 | IRAK4 | 2.71590935 |
9 | RIPK4 | 2.67054449 |
10 | IKBKB | 2.65029768 |
11 | BLK | 2.58358478 |
12 | JAK1 | 2.48053964 |
13 | ERN1 | 2.45632952 |
14 | JAK3 | 2.40695770 |
15 | PRPF4B | 2.36660905 |
16 | TAOK3 | 2.30604380 |
17 | TAOK1 | 2.21884255 |
18 | TGFBR2 | 1.98285205 |
19 | RIPK1 | 1.95671013 |
20 | * IRAK3 | 1.91230546 |
21 | CHUK | 1.84083128 |
22 | MOS | 1.77057770 |
23 | ADRBK2 | 1.76984334 |
24 | KIT | 1.73472593 |
25 | EPHB1 | 1.68033104 |
26 | MST4 | 1.64058152 |
27 | ZAP70 | 1.53313422 |
28 | CSK | 1.52199229 |
29 | FGFR4 | 1.48339547 |
30 | STK10 | 1.48330154 |
31 | MAP3K13 | 1.44283398 |
32 | PBK | 1.42063684 |
33 | PIM1 | 1.41596358 |
34 | CDC42BPA | 1.40235232 |
35 | PIM2 | 1.39685519 |
36 | CSF1R | 1.35746564 |
37 | HCK | 1.35258879 |
38 | IRAK2 | 1.32865282 |
39 | RPS6KA4 | 1.30315342 |
40 | TEC | 1.28363772 |
41 | MAP3K1 | 1.27654530 |
42 | NEK9 | 1.22858404 |
43 | SYK | 1.20475612 |
44 | BTK | 1.18715061 |
45 | JAK2 | 1.15790081 |
46 | FGFR3 | 1.15313779 |
47 | EPHA3 | 1.12663454 |
48 | MARK3 | 1.12027237 |
49 | ITK | 1.09665662 |
50 | LYN | 1.08668447 |
51 | SIK1 | 1.08660497 |
52 | CAMK1D | 1.08344576 |
53 | LCK | 1.02094348 |
54 | LATS2 | 1.01155570 |
55 | MST1R | 0.99891139 |
56 | TYRO3 | 0.97426958 |
57 | PTK6 | 0.95986171 |
58 | MAP2K3 | 0.94422697 |
59 | BMX | 0.94255025 |
60 | ARAF | 0.93775041 |
61 | FGR | 0.91325110 |
62 | EIF2AK2 | 0.88209616 |
63 | ACVR1B | 0.87585127 |
64 | MATK | 0.86208687 |
65 | GRK6 | 0.84110678 |
66 | MAP3K3 | 0.78861542 |
67 | IRAK1 | 0.78418463 |
68 | TESK2 | 0.78134267 |
69 | TRPM7 | 0.75714871 |
70 | SIK3 | 0.74528428 |
71 | TRIB3 | 0.71100813 |
72 | NLK | 0.70570312 |
73 | ABL1 | 0.69304306 |
74 | FES | 0.67483927 |
75 | PDGFRA | 0.63813944 |
76 | CAMKK2 | 0.63565880 |
77 | PRKG2 | 0.63110713 |
78 | LRRK2 | 0.61941062 |
79 | ABL2 | 0.59181210 |
80 | DAPK2 | 0.59012007 |
81 | CDK6 | 0.58879069 |
82 | SIK2 | 0.58720973 |
83 | CDK12 | 0.57927703 |
84 | STK3 | 0.57196406 |
85 | EGFR | 0.56183447 |
86 | MAP3K5 | 0.53469588 |
87 | NME2 | 0.52159572 |
88 | STK4 | 0.51221820 |
89 | PRKCD | 0.50288240 |
90 | NUAK1 | 0.50042407 |
91 | PRKAA2 | 0.49335684 |
92 | MAP3K10 | 0.49189128 |
93 | GRK7 | 0.47396232 |
94 | MAPK15 | 0.47260281 |
95 | CLK1 | 0.45187360 |
96 | PIK3CG | 0.44872129 |
97 | PDGFRB | 0.44086946 |
98 | MAP2K6 | 0.44011448 |
99 | HIPK2 | 0.43960209 |
100 | GSK3A | 0.42625860 |
101 | PRKCQ | 0.41630012 |
102 | CAMK1G | 0.41467995 |
103 | YES1 | 0.41041953 |
104 | IGF1R | 0.40714589 |
105 | BMPR2 | 0.40554367 |
106 | MAP3K11 | 0.40357175 |
107 | MAPKAPK2 | 0.40188083 |
108 | GRK1 | 0.39858929 |
109 | MAPK7 | 0.38570072 |
110 | MAPK11 | 0.36997025 |
111 | MAPK12 | 0.36005890 |
112 | ERBB4 | 0.35879160 |
113 | MAPK4 | 0.35817884 |
114 | KDR | 0.35433161 |
115 | SGK3 | 0.34422013 |
116 | TIE1 | 0.33907033 |
117 | PAK4 | 0.33891090 |
118 | DYRK3 | 0.32850600 |
119 | PKN1 | 0.31935028 |
120 | TAOK2 | 0.30982828 |
121 | INSR | 0.30737371 |
122 | PDK1 | 0.30049013 |
123 | PDPK1 | 0.30024029 |
124 | STK24 | 0.28656369 |
125 | KSR2 | 0.27714546 |
126 | MELK | 0.24100704 |
127 | TTN | 0.21828239 |
128 | ICK | 0.21544324 |
129 | DAPK3 | 0.18533014 |
130 | TESK1 | 0.17807776 |
131 | MAP3K9 | 0.16538865 |
132 | MAP3K8 | 0.16007972 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.20211691 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.98695354 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.84401234 |
4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.78359580 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51689370 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.38744333 |
7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.36333399 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.31002254 |
9 | Legionellosis_Homo sapiens_hsa05134 | 2.18765686 |
10 | Malaria_Homo sapiens_hsa05144 | 2.06579085 |
11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01030447 |
12 | Measles_Homo sapiens_hsa05162 | 1.99777741 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96952937 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95774720 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95215964 |
16 | Pertussis_Homo sapiens_hsa05133 | 1.90829097 |
17 | Allograft rejection_Homo sapiens_hsa05330 | 1.83519448 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.80562279 |
19 | * Tuberculosis_Homo sapiens_hsa05152 | 1.79800902 |
20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69196294 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.68287123 |
22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66898320 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.53669668 |
24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52401833 |
25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51570654 |
26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51269134 |
27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49867927 |
28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44442048 |
29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.38295259 |
30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37783793 |
31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.33553346 |
32 | Apoptosis_Homo sapiens_hsa04210 | 1.29119558 |
33 | Asthma_Homo sapiens_hsa05310 | 1.27554396 |
34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25646154 |
35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22735560 |
36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.20852816 |
37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19091658 |
38 | Bladder cancer_Homo sapiens_hsa05219 | 1.17038425 |
39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16688206 |
40 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14747002 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.14464979 |
42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.11129482 |
43 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10329399 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.08246796 |
45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00470065 |
46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.99754544 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99603696 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96641812 |
49 | Hepatitis B_Homo sapiens_hsa05161 | 0.94955809 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94439663 |
51 | Shigellosis_Homo sapiens_hsa05131 | 0.93858696 |
52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93568291 |
53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93336371 |
54 | Phagosome_Homo sapiens_hsa04145 | 0.92860127 |
55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92140938 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90427832 |
57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.89040847 |
58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86985178 |
59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83662652 |
60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74700412 |
61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71708415 |
62 | ABC transporters_Homo sapiens_hsa02010 | 0.71589663 |
63 | Amoebiasis_Homo sapiens_hsa05146 | 0.70645339 |
64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69097753 |
65 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67641491 |
66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66419504 |
67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65553367 |
68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64705362 |
69 | Peroxisome_Homo sapiens_hsa04146 | 0.63873328 |
70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63257110 |
71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62155477 |
72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61291737 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61108870 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58735740 |
75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56378754 |
76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55496021 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.55146164 |
78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55132748 |
79 | Mineral absorption_Homo sapiens_hsa04978 | 0.54917259 |
80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52749469 |
81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.51554919 |
82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51278313 |
83 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51165412 |
84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48458555 |
85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47808838 |
86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47102343 |
87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45748739 |
88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44355113 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43848209 |
90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43696974 |
91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42606351 |
92 | Prion diseases_Homo sapiens_hsa05020 | 0.42568977 |
93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41922121 |
94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41209399 |
95 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38999555 |
96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38697391 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.38605968 |
98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37763736 |
99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36909667 |
100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36213571 |
101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34442099 |
102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34185836 |
103 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33989549 |
104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.33987718 |
105 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33320458 |
106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33052343 |
107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.32460362 |
108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31838504 |
109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30973332 |
110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29900316 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27166961 |
112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26970999 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25393119 |
114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.25267749 |
115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24263840 |
116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24162964 |
117 | Endocytosis_Homo sapiens_hsa04144 | 0.23503867 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22597752 |
119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21175462 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20870340 |
121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.20504903 |
122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17146059 |
123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15645173 |